Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice
Authors:
- 1 August 1993
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 61 (8) , 3392-402
Abstract
In earlier studies using a streptomycin-treated mouse model of infection caused by enterohemorrhagic Escherichia coli (EHEC), animals fed Shiga-like toxin type II (SLT-II)-producing strains developed acute renal cortical necrosis and died, while mice fed Shiga-like toxin type I (SLT-I)-producing clones did not die (E. A. Wadolkowski, L. M. Sung, J. A. Burris, J. E. Samuel, and A. D. O'Brien, Infect. Immun. 58:3959-3965, 1990). To examine the bases for the differences we noted between the two toxins in the murine infection model, we injected mice with purified toxins and carried out histopathological examinations. Despite the genetic and structural similarities between the two toxins, SLT-II had a 50% lethal dose (LD50) which was approximately 400 times lower than that of SLT-I when injected intravenously or intraperitoneally into mice. Histopathologic examination of toxin-injected mice revealed that detectable damage was limited to renal cortical tubule epithelial cells. Passive administration of anti-SLT-II antibodies protected mice from SLT-II-mediated kidney damage and death. Immunofluorescence staining of normal murine kidney sections incubated with purified SLT-I or SLT-II demonstrated that both toxins bound to cortical tubule and medullary duct epithelial cells. Compared with SLT-I, SLT-II was more heat and pH stable, suggesting that SLT-II is a relatively more stable macromolecule. Although both toxins bound to globotriaosylceramide, SLT-I bound with a higher affinity in a solid-phase binding assay. Differences in enzymatic activity between the two toxins were not detected. These data suggest that structural/functional differences between the two toxins, possibly involving holotoxin stability and/or receptor affinity, may contribute to the differential LD50s in mice.Keywords
This publication has 37 references indexed in Scilit:
- Evaluation of the Role of Shiga and Shiga-like Toxins in Mediating Direct Damage to Human Vascular Endothelial CellsThe Journal of Infectious Diseases, 1991
- Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II familyJournal of General Microbiology, 1990
- Toxin Genotypes and Plasmid Profiles as Determinants of Systemic Sequelae in Escherichia coli O157:H7 InfectionsThe Journal of Infectious Diseases, 1989
- Verotoxin Receptor Glycolipid in Human Renal TissueNephron, 1989
- Globotriosyl ceramide is specifically recognized by the escherichia coli verocytotoxin 2Biochemical and Biophysical Research Communications, 1988
- Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomesEuropean Journal of Biochemistry, 1988
- Colonic Hemorrhage Produced in Mice by a Unique Vero Cell Cytotoxin from an Escherichia coli Strain That Causes Hemorrhagic ColitisThe Journal of Infectious Diseases, 1987
- Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.Journal of Experimental Medicine, 1984
- Vero Cell Toxins in Escherichia coli and Related Bacteria: Transfer by Phage and Conjugation and Toxic Action in Laboratory Animals, Chickens and PigsMicrobiology, 1983
- Inhibition of protein synthesis by Shiga toxinFEBS Letters, 1980